Theravance's drug grips the bacterial membrane more tightly than vancomcyin, enabling it to kill faster.
FORBES: On The Cover/Top Stories
Theravance shares soared almost 14 percent in premarket trading 45 minutes before the market opening.
WSJ: Elan enters $1B royalty deal with Theravance
Leading the group were shares of Theravance (THRX), up about 15.8% and shares of Affymax (AFFY) up about 11.8% on the day.
FORBES: Santarus
应用推荐
模块上移
模块下移
不移动